Regarding other cardiovascular treatments, above 51% of patients in the LADA-PC study received a renin-angiotensin inhibitor for arterial hypertension, sixty-four percent received lipid-lowering treatment and 14% antiplatelet agents. Here, REN is linked to Hypertension.